We are live on
!
Find out more
Amphastar Pharmaceuticals
AMPH
AMPH
85 hedge funds and large institutions have $234M invested in Amphastar Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 36 increasing their positions, 14 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,222% more call options, than puts
Call options by funds: $304K | Put options by funds: $23K
650% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 4
157% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 14
48% more capital invested
Capital invested by funds: $158M → $234M (+$75.7M)
44% more funds holding
Funds holding: 59 → 85 (+26)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
85
Holders Change
+26
Holders Change %
+44.07%
% of All Funds
2.29%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
30
Increased
36
Reduced
14
Closed
4
Calls
$304K
Puts
$23K
Net Calls
+$281K
Net Calls Change
+$281K
Top Buyers
Top Sellers
| 1 |
BC
Broadfin Capital
New York
|
-$11.1M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$10.9M |
| 3 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$8.18M |
| 4 |
JP Morgan Chase
New York
|
-$2.5M |
| 5 |
KCM
Kingdon Capital Management
New York
|
-$1.85M |
